These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 23738437)

  • 1. Antisense RNA regulation and application in the development of novel antibiotics to combat multidrug resistant bacteria.
    Ji Y; Lei T
    Sci Prog; 2013; 96(Pt 1):43-60. PubMed ID: 23738437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Designing drugs that overcome antibacterial resistance: where do we stand and what should we do?
    Penchovsky R; Traykovska M
    Expert Opin Drug Discov; 2015 Jun; 10(6):631-50. PubMed ID: 25981754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tackling Threats and Future Problems of Multidrug-Resistant Bacteria.
    Medina E; Pieper DH
    Curr Top Microbiol Immunol; 2016; 398():3-33. PubMed ID: 27406189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antimicrobial resistance and dissemination of multidrug resistant organisms-A review].
    Wang J; Wang X; Xu H
    Wei Sheng Wu Xue Bao; 2016 Nov; 56(11):1671-9. PubMed ID: 29741829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antisense inhibition of gene expression and growth in gram-negative bacteria by cell-penetrating peptide conjugates of peptide nucleic acids targeted to rpoD gene.
    Bai H; You Y; Yan H; Meng J; Xue X; Hou Z; Zhou Y; Ma X; Sang G; Luo X
    Biomaterials; 2012 Jan; 33(2):659-67. PubMed ID: 22000398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibacterial Peptide Nucleic Acids-Facts and Perspectives.
    Wojciechowska M; Równicki M; Mieczkowski A; Miszkiewicz J; Trylska J
    Molecules; 2020 Jan; 25(3):. PubMed ID: 32012929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibiotics-Peptide Conjugates Against Multidrug-resistant Bacterial Pathogens.
    David AA; Park SE; Parang K; Tiwari RK
    Curr Top Med Chem; 2018; 18(22):1926-1936. PubMed ID: 30499392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current Technology in the Discovery and Development of Novel Antibacterials.
    Chung PY
    Curr Drug Targets; 2018; 19(7):832-840. PubMed ID: 28891454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Antibacterial Activity of Metal Complexes Containing 1,10- phenanthroline: Potential as Alternative Therapeutics in the Era of Antibiotic Resistance.
    Viganor L; Howe O; McCarron P; McCann M; Devereux M
    Curr Top Med Chem; 2017; 17(11):1280-1302. PubMed ID: 27697043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thymol-Decorated Gold Nanoparticles for Curing Clinical Infections Caused by Bacteria Resistant to Last-Resort Antibiotics.
    Huang Z; Zhang X; Yao Z; Han Y; Ye J; Zhang Y; Chen L; Shen M; Zhou T
    mSphere; 2023 Jun; 8(3):e0054922. PubMed ID: 37017551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Quest to the Therapeutic Arsenal: Novel Strategies to Combat Multidrug- resistant Bacteria.
    Ashwath P; Sannejal AD
    Curr Gene Ther; 2022; 22(2):79-88. PubMed ID: 33874870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antisense antibiotics: a brief review of novel target discovery and delivery.
    Bai H; Xue X; Hou Z; Zhou Y; Meng J; Luo X
    Curr Drug Discov Technol; 2010 Jun; 7(2):76-85. PubMed ID: 20836761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antisense antibacterial compounds.
    Pifer R; Greenberg DE
    Transl Res; 2020 Sep; 223():89-106. PubMed ID: 32522669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacterial genome engineering and synthetic biology: combating pathogens.
    Krishnamurthy M; Moore RT; Rajamani S; Panchal RG
    BMC Microbiol; 2016 Nov; 16(1):258. PubMed ID: 27814687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Highly sensitive target-based whole-cell antibacterial discovery strategy by antisense RNA silencing.
    Singh SB; Phillips JW; Wang J
    Curr Opin Drug Discov Devel; 2007 Mar; 10(2):160-6. PubMed ID: 17436551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reprogramming of antibiotics to combat antimicrobial resistance.
    Dubey KK; Indu ; Sharma M
    Arch Pharm (Weinheim); 2020 Nov; 353(11):e2000168. PubMed ID: 32776618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combating multidrug-resistant bacteria: current strategies for the discovery of novel antibacterials.
    O'Connell KM; Hodgkinson JT; Sore HF; Welch M; Salmond GP; Spring DR
    Angew Chem Int Ed Engl; 2013 Oct; 52(41):10706-33. PubMed ID: 24038605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multidrug-resistant gram-negative organisms: a review of recently approved antibiotics and novel pipeline agents.
    Provenzani A; Hospodar AR; Meyer AL; Leonardi Vinci D; Hwang EY; Butrus CM; Polidori P
    Int J Clin Pharm; 2020 Aug; 42(4):1016-1025. PubMed ID: 32638294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microwave-assisted solid-phase synthesis of antisense acpP peptide nucleic acid-peptide conjugates active against colistin- and tigecycline-resistant E. coli and K. pneumoniae.
    Hansen AM; Bonke G; Hogendorf WFJ; Björkling F; Nielsen J; Kongstad KT; Zabicka D; Tomczak M; Urbas M; Nielsen PE; Franzyk H
    Eur J Med Chem; 2019 Apr; 168():134-145. PubMed ID: 30807888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting RNA polymerase primary σ70 as a therapeutic strategy against methicillin-resistant Staphylococcus aureus by antisense peptide nucleic acid.
    Bai H; Sang G; You Y; Xue X; Zhou Y; Hou Z; Meng J; Luo X
    PLoS One; 2012; 7(1):e29886. PubMed ID: 22253815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.